Tag: TMST

  • Why the Timken Steep Corp (TMST) Shares have been on a skywalk?

    Why the Timken Steep Corp (TMST) Shares have been on a skywalk?

    Brief:

    Shares of Timken Steep Corp.(TMST) stock have been on the skywalk. The manufacturer of alloy steel has recorded a jump over 9.26% on Wednesday after the green light given by the KeyBanc Capital analyst Phillip Gibbs that it is the right time to buy shares of this stock as macroeconomic recovery is in progress.

    What’s happening?

    The closing price of TMST reached its highest level since May 2019. The rating has been raised to overweight from sector weight by Gibbs with a target price of 10$. Gibbs’s views reflect that the company will outperform in the future due to microeconomic recovery, a better contract, and spot pricing, widening raw material spreads, as well as “self-help,” which includes cost cuts.

    Rebound in oil prices could be another reason for the stock price to increase as demand for oil, after facing the dark days in winter, would increase in summer but it would depend on the rollout of vaccination which is expected to get pace in summer.

    The company is in the sight of investors and traders as it is going to announce its 2020 fourth quarter and full-year financial results on the 25th of February,2021. The company had recorded sales of 1.2$ billion in 2019 and employed 2150 people.

    Conclusion:

    The bullish sentiment is in favor of TMTX after the positive statement of the KeyBanc Capital analyst Phillip Gibbs. The stock has been continuously pumping high for the past three months. The fourth quarter and full-year financial results would further decide the fate of the company.

  • Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

    Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

    US stock exchanges fell on Monday in line with the overall decline in risk sentiment in global markets, according to trading data.

    The Dow Jones Industrial Average (DJIA) fell by 0.33% to 31391.89 points, the NASDAQ high-tech index – by 0.86% to 13756.78 points, the broad market S&P 500 index – by 0.47%, up to 3887.8 points.

    Monday traders are risk averse. Their attention turned to the possible consequences of the economic recovery after the pandemic. In particular, investors are concerned that the US $1.9 trillion stimulus package will lead to increased economic activity and a surge in inflation, which in turn could prompt the Fed to tighten monetary policy.

    At preliminary trades, the pressure on the share price was also exerted by the growth of the yield on US government bonds to the maximum since February last year, which contributed to the strengthening of the dollar. However, the yield on government bonds has already moved to a correctional decline. The dollar is also slightly declining.

    Meanwhile, the shares of the American concern Boeing are losing 1.8% after the company recommended to suspend flights of 777 liners with a Pratt & Whitney PW4000-112 engine amid an emergency with an engine in Colorado.

    Today Top Movers‎

    ReTo Eco-Solutions Inc. (NASDAQ: RETO) shares are trading up 36.75% at $3.2 at the time of writing.

    Vascular Biogenics Ltd (VBLT) jumper over 58.30% at $3.53 in pre-market trading today after declaring results of the independent Data Safety Monitoring Committee pre-planned review of the ongoing OVAL Phase 3 registration enabling study of VB-111 in recurrent ovarian cancer. ‎

    TFF Pharmaceuticals Inc. (TFFP) stock soared 10.2% to $17.5 in the pre-market ‎trading.

    Celsion Corporation (CLSN), a biotechnology company, dropped about -22.42% at $2.18 in pre-market trading Tuesday after receiving FDA fast track designation for GEN-1 in Advanced Ovarian Cancer.‎ ‎

    Top Upgrades & Downgrades

    KeyBanc turned bullish on iQIYI Inc. (IQ), upgrading the stock to “Overweight” and assigning a $30.0 price target, representing a potential upside of 25.63% from Monday’s close. 

    TimkenSteel Corporation (TMST) has won the favor of KeyBanc’s equity research team. The firm upgraded the shares from Sector Weight to Overweight and moved their price target to $10.0, suggesting 58.98% additional upside for the stock. 

    Vertex Pharmaceuticals Incorporated (VRTX) received an upgrade from analysts at Baird, who also set their one-year price target on the stock to $252. They changed their rating on VRTX to Outperform from Neutral in a recently issued research note.

    Earlier Tuesday Jefferies reduced its rating on GasLog Ltd. (GLOG) stock to Hold from Buy and assigned the price target to $5.8. 

    Evercore ISI analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Principal Financial Group Inc. (PFG) has been changed to In Line from Outperform and the new price target is set at $63. 

    Analysts at Societe Generale downgraded DISH Network Corporation (DISH)’s stock to Sell from Hold Tuesday.

    Latest Insider Activity

    Pinterest Inc. (PINS) Director Levine Jeremy S. announced the sale of shares taking place on Feb 19 at $86.47 for some 150,000 shares. The total came to more than $12.97 million. 

    Coeur Mining Inc. (CDE) SVP, Exploration Rasmussen Hans John sold on Feb 22 a total 309,185 shares at $8.91 on average. The insider’s sale generated proceeds of almost $32967. 

    SLM Corporation (SLM) Director Franke Mary Carter Warren declared the purchase of shares taking place on Feb 17 at $15.03 for some 7,000 shares. The transaction amount was around $0.11 million. 

    Corvus Pharmaceuticals Inc. (CRVS) President and CEO MILLER RICHARD A MD bought on Feb 17 a total 1,278,515 shares at $3.50 on average. The purchase cost the insider an estimated $350,000.

    Important Earnings

    Top US earnings releases scheduled for today include Macy’s Inc. (NYSE: M). It will announce its Jan 2021 financial results. The company is expected to report earnings of $0.12 per share from revenues of $6.5B in the three-month period. 

    Analysts expect Square, Inc. (SQ) to report a net income (adjusted) of $0.24 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $3.09B. 

    B2Gold Corp. (BTG), due to announce earnings after the market closes today, is expected to report earnings of $0.01 per share from revenues of $207.75M recently concluded three-month period.